The company’s Repatha (evolocumab) was added to optimised statin therapy in a phase 3 trial, and resulted in statistically significant regression of atherosclerosis in patients with coronary ...

Repatha (evolocumab) will be sold in the UK at a cost of $6,780 per year, less than half the $14,100 Amgen is charging for the drug in the US, with the price in other EU markets typically below ...

It’s not known whether Repatha (evolocumab) is safe to use while pregnant or breastfeeding. Certain factors may determine whether you should use the drug during this time. It’s not known ...

Dosage for Repatha (evolocumab) may vary based on the condition it’s being used to treat. You might take 140 milligrams (mg) or 420 mg every 2 weeks, or you might take 420 mg monthly.

An expensive new drug, evolocumab (Repatha), developed by Amgen, significantly drops cholesterol levels and reduced the risk of major cardiovascular events, researchers reported in a study published ...

[Robinson JG. Clinical Lipid Management;455a] Alirocumab (Praluent, Regeneron) and evolocumab (Repatha, Amgen) are the two mAbs currently approved by the FDA; both received approval in 2015.

She prescribed Repatha injections instead. They control my cholesterol without causing extreme pain. I am grateful. A. Almost a decade ago, the FDA approved two new drugs to lower LDL cholesterol.

oTobacco use and excessive alcohol consumption. oHigh blood pressure and genetic predisposition. .Repatha (evolocumab) is a cholesterol-lowering treatment that helps reduce LDL cholesterol levels ...